LEVOLTAPHARMA.COM SERVER
Our parsers found that a single page on levoltapharma.com took five hundred and forty-six milliseconds to come up. Our parsers could not discover a SSL certificate, so our crawlers consider levoltapharma.com not secure.
Internet Protocol
69.168.8.230
SERVER OS AND ENCODING
We revealed that levoltapharma.com is using the nginx server.HTML TITLE
Levolta Pharmaceuticals, IncDESCRIPTION
Investors Media. Surpassing current treatment barriers by developing products with an enhanced therapeutic index that drive customer value. Levolta Pharmaceuticals Presents Phase II Study Results for Potential Osteoarthritis Therapy at ACR Annual Meeting. Levolta Pharmaceuticals Receives U.S. Patent for Novel Investigational Therapy for Controlling Osteoarthritis. 116 Research Dr., Bethlehem, PA 18015. P 848.702.0682 - Email Us. Website Design and Hosting by Tidal Media Group.PARSED CONTENT
The web site states the following, "Surpassing current treatment barriers by developing products with an enhanced therapeutic index that drive customer value." We noticed that the web site also said " Levolta Pharmaceuticals Presents Phase II Study Results for Potential Osteoarthritis Therapy at ACR Annual Meeting." It also said " Patent for Novel Investigational Therapy for Controlling Osteoarthritis. , Bethlehem, PA 18015. Website Design and Hosting by Tidal Media Group."